SPY—QQQ719.02+0.09%BTC/USD—DIA519.52+0.12%GLD378.71−0.26%TLT79.52+0.08%
Benzinga
Updated: Oct 19, 2026

Dev Prasad 's Stock Ratings

LUCID CAPITAL MARKETS Analyst

Dev Prasad is an analyst at LUCID CAPITAL MARKETS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.

Overall Average Return

30.0%

Smart Score

57.8%

Overall Average Return Percentile

86th

Number of Ratings

12
Buy NowGet Alert
09/24/2026TTRXBuy Now
Turn Therapeutics
$10.64125.56% → $24Initiates → BuyGet Alert
09/14/2026FTHBuy Now
Faeth Therapeutics
$18.80213.83% → $59Initiates → BuyGet Alert
09/08/2026ANLBuy Now
Adlai Nortye
$10.58363.14% → $49Assumes → BuyGet Alert
08/20/2026ELOXBuy Now
Eloxx Pharma
$12.50204% → $38Initiates → BuyGet Alert
07/27/2026PLYXBuy Now
Polaryx Therapeutics
$1.89270.37% → $7Initiates → BuyGet Alert
05/04/2026QNRXBuy Now
Quoin Pharmaceuticals
$3.98653.77% → $30Initiates → BuyGet Alert
09/15/2025ATYRBuy Now
aTyr Pharma
$0.17482.41%$11 → $1DowngradeBuy → NeutralGet Alert
08/25/2025CUEBuy Now
Cue Biopharma
$17.77-77.49% → $4Initiates → BuyGet Alert
06/17/2025IRDBuy Now
Opus Genetics
$3.8230.93% → $5Initiates → BuyGet Alert
12/17/2024CALCBuy Now
CalciMedica
$1.091092.66% → $13Initiates → BuyGet Alert
12/17/2024AVTXBuy Now
Avalo Therapeutics
$11.59107.08% → $24Initiates → BuyGet Alert
12/17/2024IBIOBuy Now
iBio
$0.77680.23% → $6Initiates → BuyGet Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved